Damora Therapeutics, Inc.

NASDAQ:DMRA

Biotechnology

Healthcare
$22.98 +0.34%

+$0.07 today

Market cap
$1.42B
Beta
1.48
P/E (TTM)
-0.1
EPS (TTM)
-$177.15
52W Low $2.45High $38.33

Volume 0.58M

Average 0.33M

Balance Sheet

Inspect the capital base behind the business.

Assets

$260.53M

FY 2025 · Annual

+1420.7% YoY

Liabilities

$20.15M

FY 2025 · Annual

+657.1% YoY

Equity

$240.38M

FY 2025 · Annual

+1561.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents62.56M32.79M21.47M14.18M257.62M
Short-term Investments37.63M27.44M11.69M00
Net Receivables2.28M1.38M1.72M881K899K
Inventory00000
Other Current Assets5.9M1.5M1.13M1.19M1.32M
Total Current Assets110.1M63.91M36.77M16.84M260.42M
Property, Plant & Equipment (Net)1.04M1.17M325K130K104K
Goodwill00000
Intangible Assets00000
Long-term Investments9.05M5.83M000
Tax Assets00000
Other Non-current Assets2.03M2.28M1.13M163K0
Total Non-current Assets12.11M9.28M1.45M293K104K
Total Assets122.22M73.19M38.23M17.13M260.53M
Account Payables1.53M3.35M1.7M377K444K
Short-term Debt399K476K183K12K0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities2.01M6.68M2.96M604K1.52M
Total Current Liabilities4.54M11.11M5.83M1.2M20.07M
Long-term Debt0001.36M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00043K28K
Total Non-current Liabilities448K328K66K1.46M81K
Total Liabilities4.99M11.44M5.9M2.66M20.15M
Common Stock00000
Retained Earnings(156.11M)(217.74M)(256.08M)(277.52M)(487.36M)
Accumulated OCI(320K)(244K)380K97K802K
Other Stockholders Equity00000
Minority Interest00000
Total Equity117.22M61.75M32.33M14.47M240.38M
Total Debt847K804K249K1.43M68K
Net Debt(61.72M)(31.98M)(21.22M)(12.74M)(257.56M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$532.9M
Receivables$894.0K
Other Current$1.6M
Total Current Assets$535.4M
Other Non-current$34.0K
Total Non-current Assets$34.0K
Total Assets$535.4M

Analysis

Selected assets total $535.4M for Latest. The largest visible component is Cash & Equivalents at $532.9M, about 99.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipSep 28, 2026
4Statement of changes in beneficial ownershipAug 13, 2026
3Initial statement of beneficial ownershipAug 13, 2026
EFFECTEFFECT filingAug 12, 2026

How much cash does DMRA have?

Damora Therapeutics, Inc. (DMRA) reported $257.62M in cash and equivalents in fiscal 2025.

How much debt does DMRA carry?

Damora Therapeutics, Inc. (DMRA) reported $68,000.00 of total debt, with net debt of -$257.56M.